Skip to main content

Health Catalyst, Inc.

corporate_fare Company Profile

Health Catalyst, Inc.

HCAT·NASDAQ·Technology·CIK 0001636422

Health Catalyst is a leading provider of data and analytics technology and services for healthcare organizations. The company's Solution includes a cloud-based data and analytics platform, software applications, and specialized expertise. Healthcare providers, who are the primary clients, utilize this Solution to manage their data, gain analytical insights for organizational operations, and achieve measurable improvements in clinical, financial, and operational areas. The company's mission is to be a catalyst for massive, measurable, data-informed healthcare improvement. This is achieved through several key elements: a Data and Analytics Platform that integrates data in a flexible, open, scalable, and modular way to power insights; Applications that deliver analytics insights for measurable improvement and automate processes for efficiency; and Expertise, which enables data-informed improvement through specialized knowledge and managed services. These components collectively drive measurable improvements, fostering client trust and engagement. The company also prioritizes team member engagement, which is foundational to its operations and client success. As clients realize improvements, their trust in Health Catalyst grows, leading to increased engagement, renewals, expansions, and referrals to other potential clients.

Health Catalyst, Inc. (NASDAQ:HCAT) is a publicly traded company in the Technology sector. Wiseek has independently scored 28 items for HCAT at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-05, rated 7/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 12 rated 8 or above. Recent SEC coverage for HCAT spans 10-Q, SCHEDULE 13D/A, 8-K, SCHEDULE 13D.

Recent high-impact activity:

  • Health Catalyst 10-Q: $40.5M Q3 Profit on Vitalware Gain, $122.5M Impairment, Debt Wiped Out
  • Health Catalyst Posts $40.5M Q3 Net Income
  • Activist Palogic Raises Stake to 7.1% and Demands Business Plan, R&D Cost Split
  • Health Catalyst Appoints Simeon Kohl as CEO; Ben Albert Moves to Chief Business Officer
  • Health Catalyst Finalizes Vitalware Sale, Pays Off Debt, and Posts Q2 Upside

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$311.14M
Net Income
-$177.97M
Diluted EPS
-$2.55
Op. Cash Flow
$731K
Free Cash Flow
-$237K
Operating Income
-$160.85M
Cash & Equivalents
$50.81M
Total Debt
$153.25M
Debt / Equity
0.62×
Net Margin
-57.2%
Shares Outstanding
72.03M sh
Source: 10-K · filed 2026-04-30 · accession 0001636422-26-000055

Short Interest & Short Volume

7.18 days to cover

FINRA reported short interest of 1,952,692 shares in HCAT as of the October 30, 2026 settlement, a 5.6% decrease from the prior period — about 7.2 days to cover at its recent average daily volume. On November 20, 2026, 25.7% of HCAT volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)1,952,692 shares as of October 30, 2026
Change vs prior period▼ 5.6%
Days to cover7.18 at avg daily volume of 271,857
Daily short volume (FINRA facilities)25.7% of 198,545 shares on November 20, 2026
5-day average short volume34.3%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with H →
$1.31
52-week range · as of 2026-11-05 $0.9551 – $3.36
Market cap
$99.76M
Volume
711.6K (1.8× avg)
3-mo avg 386.7K
Live data · 2026-11-21 09:54 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed HCAT - Latest Insights

HCAT
Nov 05, 2026, 5:17 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $1.50
Real-time Price: $1.31 info
Change: -$0.190 (-13%) info
Market Cap: $99.764M info
HCAT
Nov 05, 2026, 4:03 PM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $1.50
Real-time Price: $1.31 info
Change: -$0.190 (-13%) info
Market Cap: $99.764M info
HCAT
Sep 08, 2026, 5:04 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $1.70
Real-time Price: $1.31 info
Change: -$0.390 (-23%) info
Market Cap: $99.764M info
HCAT
Sep 08, 2026, 8:13 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.63
Real-time Price: $1.31 info
Change: -$0.320 (-20%) info
Market Cap: $99.764M info
HCAT
Aug 06, 2026, 4:09 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.67
Real-time Price: $1.31 info
Change: -$0.360 (-22%) info
Market Cap: $99.764M info
HCAT
Aug 06, 2026, 4:03 PM EDT
Source: PR Newswire
Importance Score:
7
Price at Filing: $1.86
Real-time Price: $1.31 info
Change: -$0.550 (-30%) info
Market Cap: $99.764M info
HCAT
Jul 17, 2026, 6:40 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $2.20
Real-time Price: $1.31 info
Change: -$0.890 (-40%) info
Market Cap: $99.764M info
HCAT
Jun 22, 2026, 3:55 PM EDT
Filing Type: SCHEDULE 13D
Importance Score:
9
Price at Filing: $1.69
Real-time Price: $1.31 info
Change: -$0.375 (-22%) info
Market Cap: $99.764M info
HCAT
Jun 08, 2026, 7:12 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $1.72
Real-time Price: $1.31 info
Change: -$0.4142 (-24%) info
Market Cap: $99.764M info
HCAT
Jun 04, 2026, 9:10 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $1.56
Real-time Price: $1.31 info
Change: -$0.245 (-16%) info
Market Cap: $99.764M info
HCAT
Jun 04, 2026, 9:03 AM EDT
Source: GlobeNewswire
Importance Score:
9
Price at Filing: $1.55
Real-time Price: $1.31 info
Change: -$0.240 (-15%) info
Market Cap: $99.764M info
HCAT
Jun 03, 2026, 4:11 PM EDT
Filing Type: DEF 14A
Importance Score:
8
Price at Filing: $1.33
Real-time Price: $1.31 info
Change: -$0.020 (-2%) info
Market Cap: $99.764M info
HCAT
May 19, 2026, 4:12 PM EDT
Filing Type: PRE 14A
Importance Score:
8
Price at Filing: $1.27
Real-time Price: $1.31 info
Change: +$0.040 (+3%) info
Market Cap: $99.764M info
HCAT
May 11, 2026, 5:03 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $1.57
Real-time Price: $1.31 info
Change: -$0.260 (-17%) info
Market Cap: $99.764M info
HCAT
May 11, 2026, 4:12 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $1.40
Real-time Price: $1.31 info
Change: -$0.090 (-6%) info
Market Cap: $99.764M info
HCAT
May 11, 2026, 4:10 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $1.40
Real-time Price: $1.31 info
Change: -$0.090 (-6%) info
Market Cap: $99.764M info
HCAT
Apr 30, 2026, 5:19 PM EDT
Filing Type: 10-K/A
Importance Score:
8
Price at Filing: $1.25
Real-time Price: $1.31 info
Change: +$0.060 (+5%) info
Market Cap: $99.764M info
HCAT
Apr 30, 2026, 9:22 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.24
Real-time Price: $1.31 info
Change: +$0.070 (+6%) info
Market Cap: $99.764M info
HCAT
Apr 27, 2026, 9:00 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.31
Real-time Price: $1.31 info
Change: $0 (0%) info
Market Cap: $99.764M info
HCAT
Apr 02, 2026, 5:56 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.17
Real-time Price: $1.31 info
Change: +$0.140 (+12%) info
Market Cap: $99.764M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets